Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D, Certain MC, Weatherald J, Jaïs X, Bulifon S, Noel-Savina E, Nieves A, Renard S, Traclet J, Bouvaist H, Riou M, de Groote P, Moceri P, Bertoletti L, Favrolt N, Guillaumot A, Jutant EM, Beurnier A, Boucly A, Ebstein N, Jevnikar M, Pichon J, Keddache S, Preda M, Roche A, Solinas S, Seferian A, Reynaud-Gaubert M, Cottin V, Savale L, Humbert M, Sitbon O; French PH Network PULMOTENSION Investigators. Montani D, et al. Among authors: guillaumot a. Am J Respir Crit Care Med. 2022 Sep 1;206(5):573-583. doi: 10.1164/rccm.202112-2761OC. Am J Respir Crit Care Med. 2022. PMID: 35549842 Free PMC article.
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.
Chaouat A, Sitbon O, Mercy M, Ponçot-Mongars R, Provencher S, Guillaumot A, Gomez E, Selton-Suty C, Malvestio P, Regent D, Paris C, Hervé P, Chabot F. Chaouat A, et al. Among authors: guillaumot a. Eur Respir J. 2014 Sep;44(3):704-13. doi: 10.1183/09031936.00153613. Epub 2014 May 15. Eur Respir J. 2014. PMID: 24833765 Free article.
T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease.
Maurac A, Lardenois É, Eyries M, Ghigna MR, Petit I, Montani D, Guillaumot A, Caput B, Chabot F, Chaouat A. Maurac A, et al. Among authors: guillaumot a. Eur Respir J. 2019 Aug 22;54(2):1900388. doi: 10.1183/13993003.00388-2019. Print 2019 Aug. Eur Respir J. 2019. PMID: 31164435 Free article. No abstract available.
Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation.
Thoré P, Girerd B, Jaïs X, Savale L, Ghigna MR, Eyries M, Levy M, Ovaert C, Servettaz A, Guillaumot A, Dauphin C, Chabanne C, Boiffard E, Cottin V, Perros F, Simonneau G, Sitbon O, Soubrier F, Bonnet D, Remy-Jardin M, Chaouat A, Humbert M, Montani D. Thoré P, et al. Among authors: guillaumot a. Eur Respir J. 2020 May 14;55(5):1902340. doi: 10.1183/13993003.02340-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32079640 Free article.
Association between Leflunomide and Pulmonary Hypertension.
Lacoste-Palasset T, Chaumais MC, Weatherald J, Savale L, Jaïs X, Price LC, Khouri C, Bulifon S, Seferian A, Jevnikar M, Boucly A, Manaud G, Pancic S, Chabanne C, Ahmad K, Volpato M, Favrolt N, Guillaumot A, Horeau-Langlard D, Prévot G, Fesler P, Bertoletti L, Reynaud-Gaubert M, Lamblin N, Launay D, Simonneau G, Sitbon O, Perros F, Humbert M, Montani D. Lacoste-Palasset T, et al. Among authors: guillaumot a. Ann Am Thorac Soc. 2021 Aug;18(8):1306-1315. doi: 10.1513/AnnalsATS.202008-913OC. Ann Am Thorac Soc. 2021. PMID: 33502958 Free article.
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
Valentin S, Maurac A, Sitbon O, Beurnier A, Gomez E, Guillaumot A, Textoris L, Fay R, Savale L, Jaïs X, Montani D, Picard F, Mornex JF, Prevot G, Chabot F, Humbert M, Chaouat A. Valentin S, et al. Among authors: guillaumot a. Eur Respir J. 2021 Nov 4;58(5):2004066. doi: 10.1183/13993003.04066-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 33875491 Free article.
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.
Gault N, Esposito-Farèse M, Revest M, Inamo J, Cabié A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, De Montmollin E, Oziol E, Etienne M, Laouénan C, Rossignol P, Costagliola D, Vidal-Petiot E; French-Covid cohort investigators, study group. Gault N, et al. Fundam Clin Pharmacol. 2021 Dec;35(6):1141-1158. doi: 10.1111/fcp.12683. Epub 2021 May 16. Fundam Clin Pharmacol. 2021. PMID: 33876439 Free PMC article.
65 results